Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Related Articles by Review for PubMed (Select 3908488)

1.

Beta-2 microglobulin is an amyloidogenic protein in man.

Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B.

J Clin Invest. 1985 Dec;76(6):2425-9.

2.

Is beta 2-microglobulin a mediator of bone disease?

Sprague SM, Popovtzer MM.

Kidney Int. 1995 Jan;47(1):1-6. Review. No abstract available.

PMID:
7731134
3.

Pathogenesis of beta2-microglobulin amyloidosis.

Ohashi K.

Pathol Int. 2001 Jan;51(1):1-10. Review.

PMID:
11148456
4.

The pathogenesis of beta(2)-microglobulin-induced bone lesions in dialysis-related amyloidosis.

Tran M, Rutecki GW, Sprague SM.

Semin Dial. 2001 Mar-Apr;14(2):131-3. Review.

PMID:
11264782
5.

Pathogenesis of dialysis-related amyloidosis.

Miyata T, Maeda K.

Curr Opin Nephrol Hypertens. 1995 Nov;4(6):493-7. Review.

PMID:
8591057
6.

Dialysis-related amyloidosis: late finding or hidden epidemic?

Dember LM, Jaber BL.

Semin Dial. 2006 Mar-Apr;19(2):105-9. Review.

PMID:
16551286
7.

Beta2-microglobulin and renal bone disease.

Wada T, Miyata T, Sakai H, Kurokawa K.

Perit Dial Int. 1999;19 Suppl 2:S413-6. Review.

8.

Dynamic of beta(2)-microglobulin fibril formation and reabsorption: the role of proteolysis.

Bellotti V, Gallieni M, Giorgetti S, Brancaccio D.

Semin Dial. 2001 Mar-Apr;14(2):117-22. Review.

PMID:
11264779
9.

Beta2-microglobulin and amyloidosis.

Drüeke TB.

Nephrol Dial Transplant. 2000;15 Suppl 1:17-24. Review.

10.

Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).

Floege J, Schäffer J, Koch KM.

Nephrol Dial Transplant. 2001;16 Suppl 4:12-6. Review.

11.

[Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD].

Yamamoto S, Kazama JJ.

Clin Calcium. 2007 May;17(5):740-4. Review. Japanese.

PMID:
17471004
12.

Pathogenesis and management of dialysis-related amyloid bone disease.

Nangaku M, Miyata T, Kurokawa K.

Am J Med Sci. 1999 Jun;317(6):410-5. Review.

PMID:
10372842
13.

Unifying features of systemic and cerebral amyloidosis.

Ghiso J, Wisniewski T, Frangione B.

Mol Neurobiol. 1994 Feb;8(1):49-64. Review.

PMID:
7916192
14.

Towards an understanding of the structural molecular mechanism of beta(2)-microglobulin amyloid formation in vitro.

Radford SE, Gosal WS, Platt GW.

Biochim Biophys Acta. 2005 Nov 10;1753(1):51-63. Epub 2005 Aug 15. Review.

PMID:
16099226
15.

Pathophysiology of advanced glycation end-products in renal failure.

Miyata T, Iida Y, Horie K, Cai Z, Sugiyama S, Maeda K.

Nephrol Dial Transplant. 1996;11 Suppl 5:27-30. Review.

PMID:
9044303
16.

Beta-2 microglobulin in ESRD: an in-depth review.

Winchester JF, Salsberg JA, Levin NW.

Adv Ren Replace Ther. 2003 Oct;10(4):279-309. Review.

PMID:
14681859
17.

Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.

Meredith SC.

Ann N Y Acad Sci. 2005 Dec;1066:181-221. Review.

PMID:
16533927
18.

Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.

Naiki H, Yamamoto S, Hasegawa K, Yamaguchi I, Goto Y, Gejyo F.

Amyloid. 2005 Mar;12(1):15-25. Review.

PMID:
16076607
19.

Amyloidosis.

Tan SY, Pepys MB.

Histopathology. 1994 Nov;25(5):403-14. Review.

PMID:
7868080
20.

Beta 2 microglobulin-derived amyloid in dialysis patients.

Ritz E, Deppisch R, Stein G.

Adv Exp Med Biol. 1989;260:11-8. Review. No abstract available.

PMID:
2696362
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk